| Year |
Citation |
Score |
| 2020 |
Salinas ME, Gutiérrez DA, Varela-Ramírez A, Garza KM. Continuous Exposure to Low Doses of Ultrafine Black Carbon Reduces the Vitality of Immortalized Lung-Derived Cells and Activates Senescence. Journal of Toxicology. 2020: 5702024. PMID 33488704 DOI: 10.1155/2020/5702024 |
0.309 |
|
| 2019 |
Tung K, Lou Y, Garza K, Teuscher C. Autoimmune ovarian disease: mechanism of disease induction and prevention Current Opinion in Immunology. 10: 839-45. PMID 9664065 DOI: 10.1016/S0952-7915(98)80254-9 |
0.464 |
|
| 2015 |
Camacho N, Stafford S, Garza K, Suro R, Barron K. Ultra-High Molecular Weight Polyethylene Reinforced with Multiwall Carbon Nanotubes: In Vitro Biocompatibility Study Using Macrophage-Like Cells Lubricants. 3: 597-610. DOI: 10.3390/Lubricants3030597 |
0.721 |
|
| 2014 |
Ramirez O, Motta-Mena LB, Cordova A, Estrada A, Li Q, Martinez L, Garza KM. A small library of synthetic di-substituted 1, 4-naphthoquinones induces ROS-mediated cell death in murine fibroblasts. Plos One. 9: e106828. PMID 25197824 DOI: 10.1371/journal.pone.0106828 |
0.46 |
|
| 2014 |
Ramirez O, Garza KM. Leptin deficiency in vivo enhances the ability of splenic dendritic cells to activate T cells. International Immunology. 26: 627-36. PMID 24966213 DOI: 10.1093/intimm/dxu067 |
0.484 |
|
| 2009 |
Murr L, Garza K. Natural and anthropogenic environmental nanoparticulates: Their microstructural characterization and respiratory health implications Atmospheric Environment. 43: 2683-2692. DOI: 10.1016/J.Atmosenv.2009.03.002 |
0.372 |
|
| 2008 |
Garza KM, Soto KF, Murr LE. Cytotoxicity and reactive oxygen species generation from aggregated carbon and carbonaceous nanoparticulate materials. International Journal of Nanomedicine. 3: 83-94. PMID 18488419 DOI: 10.2147/Ijn.S2464 |
0.74 |
|
| 2008 |
Soto KF, Murr LE, Garza KM. Cytotoxic responses and potential respiratory health effects of carbon and carbonaceous nanoparticulates in the Paso del Norte airshed environment. International Journal of Environmental Research and Public Health. 5: 12-25. PMID 18441401 DOI: 10.3390/Ijerph5010012 |
0.721 |
|
| 2008 |
Soto K, Garza K, Shi Y, Murr L. Direct contact cytotoxicity assays for filter-collected, carbonaceous (soot) nanoparticulate material and observations of lung cell response Atmospheric Environment. 42: 1970-1982. DOI: 10.1016/J.Atmosenv.2007.12.027 |
0.35 |
|
| 2007 |
Soto K, Garza KM, Murr LE. Cytotoxic effects of aggregated nanomaterials. Acta Biomaterialia. 3: 351-8. PMID 17275430 DOI: 10.1016/J.Actbio.2006.11.004 |
0.733 |
|
| 2006 |
Murr LE, Soto KF, Garza KM, Guerrero PA, Martinez F, Esquivel EV, Ramirez DA, Shi Y, Bang JJ, Venzor J. Combustion-generated nanoparticulates in the El Paso, TX, USA / Juarez, Mexico Metroplex: their comparative characterization and potential for adverse health effects. International Journal of Environmental Research and Public Health. 3: 48-66. PMID 16823077 DOI: 10.3390/Ijerph2006030007 |
0.746 |
|
| 2006 |
Soto K, Carrasco A, Powell T, Murr L, Garza K. Biological effects of nanoparticulate materials Materials Science and Engineering: C. 26: 1421-1427. DOI: 10.1016/J.Msec.2005.08.002 |
0.728 |
|
| 2005 |
Murr LE, Garza KM, Soto KF, Carrasco A, Powell TG, Ramirez DA, Guerrero PA, Lopez DA, Venzor J. Cytotoxicity assessment of some carbon nanotubes and related carbon nanoparticle aggregates and the implications for anthropogenic carbon nanotube aggregates in the environment. International Journal of Environmental Research and Public Health. 2: 31-42. PMID 16705799 DOI: 10.3390/Ijerph2005010031 |
0.747 |
|
| 2005 |
Soto KF, Carrasco A, Powell TG, Garza KM, Murr LE. Comparative in vitro cytotoxicity assessment of some manufacturednanoparticulate materials characterized by transmissionelectron microscopy Journal of Nanoparticle Research. 7: 145-169. DOI: 10.1007/S11051-005-3473-1 |
0.751 |
|
| 2002 |
Tung K, Agersborg S, Bagavant H, Garza K, Wei K. Autoimmune ovarian disease induced by immunization with zona pellucida (ZP3) peptide. Current Protocols in Immunology / Edited by John E. Coligan ... [Et Al.]. Unit 15.17. PMID 18432873 DOI: 10.1002/0471142735.Im1517S49 |
0.553 |
|
| 2001 |
Tung KS, Agersborg SS, Alard P, Garza KM, Lou YH. Regulatory T-cell, endogenous antigen and neonatal environment in the prevention and induction of autoimmune disease. Immunological Reviews. 182: 135-48. PMID 11722630 DOI: 10.1034/j.1600-065X.2001.1820111.x |
0.523 |
|
| 2001 |
Agersborg SS, Garza KM, Tung KS. Intestinal parasitism terminates self tolerance and enhances neonatal induction of autoimmune disease and memory. European Journal of Immunology. 31: 851-9. PMID 11241290 DOI: 10.1002/1521-4141(200103)31:3<851::AID-IMMU851>3.0.CO;2-9 |
0.513 |
|
| 2001 |
Tung KSK, Garza KM, Lou Y, Bagavant H. Autoimmune Ovarian Disease: Mechanism of Induction and Prevention Journal of the Society For Gynecologic Investigation. 8: S49-S51. DOI: 10.1177/1071557601008001S15 |
0.467 |
|
| 2000 |
Garza KM, Agersborg SS, Baker E, Tung KS. Persistence of physiological self antigen is required for the regulation of self tolerance. Journal of Immunology (Baltimore, Md. : 1950). 164: 3982-9. PMID 10754288 DOI: 10.4049/jimmunol.164.8.3982 |
0.495 |
|
| 1998 |
Garza KM, Lou YH, Tung KS. Mechanism of ovarian autoimmunity: induction of T cell and antibody responses by T cell epitope mimicry and epitope spreading. Journal of Reproductive Immunology. 37: 87-101. PMID 9571564 DOI: 10.1016/S0165-0378(97)00079-X |
0.533 |
|
| 1997 |
Tung KSK, Lou YH, Garza KM, Teuscher C. Autoimmune ovarian disease: Mechanism of disease induction and prevention Current Opinion in Immunology. 9: 839-845. PMID 9492987 DOI: 10.1016/S0952-7915(97)80187-2 |
0.513 |
|
| 1997 |
Garza KM, Griggs ND, Tung KSK. Neonatal injection of an ovarian peptide induces autoimmune ovarian disease in female mice: Requirement of endogenous neonatal ovaries Immunity. 6: 89-96. PMID 9052840 DOI: 10.1016/S1074-7613(00)80245-9 |
0.517 |
|
| 1993 |
Luo AM, Garza KM, Hunt D, Tung KS. Antigen mimicry in autoimmune disease sharing of amino acid residues critical for pathogenic T cell activation. The Journal of Clinical Investigation. 92: 2117-23. PMID 8227327 DOI: 10.1172/Jci116812 |
0.484 |
|
| Show low-probability matches. |